Gilead Sciences (GILD) Fails to deliver data

Key failure to deliver metrics for Gilead Sciences:

• Last SEC data release: 2024-12-31
• Last 15 days FTD volume: NZ$7.8 M
• Last 3 months FTD volume: NZ$36.09 M
• Last year FTD volume: NZ$36.09 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Gilead Sciences (GILD) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Gilead Sciences (GILD) - since 2013

Gilead Sciences (GILD) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Amgen AMGN	NZ$36.44 M	NZ$0.25 B	🇺🇸 USA
Vertex Pharmaceuticals VRTX	NZ$21.16 M	NZ$44.48 M	🇺🇸 USA
AbbVie ABBV	NZ$50.53 M	NZ$0.19 B	🇺🇸 USA
Illumina ILMN	NZ$26.06 M	NZ$65.83 M	🇺🇸 USA
Biogen BIIB	NZ$25 M	NZ$71.88 M	🇺🇸 USA
Pfizer PFE	NZ$37.96 M	NZ$0.35 B	🇺🇸 USA
Johnson & Johnson JNJ	NZ$22.46 M	NZ$0.33 B	🇺🇸 USA
Eli Lilly LLY	NZ$74.57 M	NZ$0.20 B	🇺🇸 USA
Merck MRK	NZ$76.67 M	NZ$0.12 B	🇺🇸 USA